Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-06-15

Clinical Trial Update: Evaluation of Fosmidomycin and Piperaquine in the Treatment of Acute Falciparum Malaria [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating fosmidomycin in combination with piperaquine for acute uncomplicated Plasmodium falciparum malaria is being conducted. The study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosmidomycin (fosmidomycin)
  • Piperaquine (Piperaquine)

Snippet

Sponsor: Jomaa Pharma GmbH | Conditions: Oral Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria | Phase 2 | Status: UNKNOWN